Announcement Of Appointment Of Chief Executive Officer
| Appointment Details | ||
| Date of Appointment | 22/05/2013 | |
| Name | Gurpreet Singh Dhillon | |
| Age | 29 | |
| Country of principal residence | Singapore | |
| The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) | The Nominating Committee had reviewed and assessed Mr Gurpreet Singh Dhillon's qualifications and his work experience. Based on Mr Gurpreet Singh Dhillon's past track record and credentials, the Nominating Committee is of the view that he will be able to add value to Religare Health Trust Trustee Manager Pte. Ltd. ('RHTTM') as the Chief Executive Officer. | |
| Whether appointment is executive, and if so, area of responsibility | Executive. Mr Gurpreet Singh Dhillon is responsible in managing the daily operations relating to RHTTM and Religare Health Trust. |
|
| Job Title | Executive Director and Chief Executive Officer | |
| Working experience and occupation(s) during the past 10 years | Mr Gurpreet Dhillon is a founding shareholder of Religare Enterprises Ltd ('REL'), the listed entity that holds RHTTM. Since being set up in 2001, REL has grown to become one of India's largest Financial Services groups with a leading presence in sectors Broking, Insurance, Lending and asset management. He has been instrumental in helping REL build its investment banking and asset management ventures in emerging markets. From 2005 to 2011, Mr Dhillon was on the Board of Directors of Religare Capital Markets Plc, the investment banking arm of REL which focuses on emerging markets. Prior to his appointment as CEO, Mr Dhillon was COO of RHTTM, where his responsibilities included overseeing operations and investments of RHT. Mr Dhillon has deep corporate finance and real estate experience, having worked on a number of Indian real estate transactions. |
|
| Interest in the listed issuer and its subsidiaries | 1,237,000 Common Units (0.16% based on total issued units of 788,131,944 units in Religare Health Trust) | |
| Family relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries | Mr Gurpreet Singh Dhillon is a second cousin of Mr Malvinder Mohan Singh and Mr Shivinder Mohan Singh, who are indirect substantial unitholders of Religare Health Trust | |
| Conflict of interest | None | |
| Other Directorship | ||
| Past (for the last five years) | ARM Corporate Finance Limited Blomfield Capital Limited Blomfield Investment Management Limited Charterpace Limited Claridge House Services Limited Religare Hichens Harrison Consultoria Internacional Ltd HH1803.Com Limited Hichens, Harrison (Commodities) Limited Hichens, Harrison (Derivatives) LLP Hichens, Harrison (Middle East) Limited Hichens, Harrison (North America) Limited Hichens, Harrison (Ventures) Limited London Wall Nominees Limited Medserve (ME) Limited Religare Capital Markets Corporate Finance Pte. Ltd. Religare Capital Markets (Europe) Limited (formerly known as Religare Capital Markets Plc) Tobler UK Limited |
|
| Present | Fortis Global Healthcare Infrastructure Pte. Ltd. One and Only Holdings Pte. Limited Religare Global Asset Management Singapore Pte. Ltd. Vistaar Religare Capital Advisers Limited |
|
| Information required pursuant to Listing Rule 704(7)(h) | ||
| a. | Whether at any time during the last 10 years, a petition under any bankruptcy laws of any jurisdiction was filed against him or against a partnership of which he was a partner? | No |
| b. | Whether at any time during the last 10 years a petition under any law of any jurisdiction was filed against a corporation of which he was a director or key executive for the winding up of that corporation on the ground of insolvency? | No |
| c. | Whether there is any unsatisfied judgement against him? | No |
| d. | Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment for 3 months or more, or has been the subject of any criminal proceedings (including any pending criminal proceedings which he is aware of) for such purpose? | No |
| e. | Whether he has ever been convicted of any offence, in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or been the subject of any criminal proceedings (including any pending criminal proceedings which he is aware of) for such breach? | No |
| f. | Whether at any time during the last 10 years, judgement has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misinterpretation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings which he is aware of involving an allegation of fraud, misinterpretation or dishonesty on his part)? | No |
| g. | Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any corporation? | No |
| h. | Whether he has ever been disqualified from acting as a director of any corporation, or from taking part directly or indirectly in the management of any corporation? | No |
| i. | Whether he has ever been the subject of any order, judgement or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? | No |
| j. | Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :- | |
| (i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or | No |
|
| (ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or | No |
|
| (iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or | No |
|
| (iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, | No |
|
| in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? | ||
| k. | Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? | No |
| Information required pursuant to Listing Rule 704(7)(i) | ||
| Any prior experience as a director of a listed company? | ||
| Other Notes | ||
| Footnotes | Nomura Singapore Limited, Religare Capital Markets Corporate Finance Pte. Limited and Standard Chartered Securities (Singapore) Pte. Limited ("Standard Chartered Securities") were the joint issue managers ("Joint Issue Managers") of the Offering. CIMB Securities (Singapore) Pte. Ltd., DBS Bank Ltd., Nomura Securities Singapore Pte. Ltd., Religare Capital Markets (Singapore) Pte. Limited and Standard Chartered Securities were the joint global coordinators, bookrunners and underwriters ("Joint Bookrunners") of the Offering. The Joint Issue Managers and the Joint Bookrunners assume no responsibility for the contents of this announcement. | |